Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen
Miriam R. Brezis, Eliya Shachar, Shira Peleg Hasson, Ido Laskov, Nadav Michaan, Bar Levy, Ido Wolf, Tamar Safra · 2023
Read Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen by Miriam R. Brezis, Eliya Shachar, Shira Peleg Hasson, Ido Laskov, Nadav Michaan, Bar Levy, Ido Wolf, Tamar Safra (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10751294.txt.
Description
Miriam Brezis and co-authors review how well standard chemotherapy serves older women with ovarian cancer in a study from 2023. Advanced ovarian cancer is treated with surgery plus a two-drug regimen. Doctors often worry that patients over seventy cannot bear the full treatment.
Records covered nine hundred fifty-six patients treated from 2002 to 2020. About a quarter were over seventy, split further into their seventies and eighties. Two schedules, weekly and every three weeks, were compared. Survival in the older group reached a median of about forty-one months. Progress-free time did not differ by age in a clear way. The data support offering standard treatment to fit older patients.
Catalog record
| CREATOR | Miriam R. Brezis, Eliya Shachar, Shira Peleg Hasson, Ido Laskov, Nadav Michaan, Bar Levy, Ido Wolf, Tamar Safra |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |